Matches in Wikidata for { <http://www.wikidata.org/entity/Q83349493> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q83349493 description "artikull shkencor i botuar më 01 shkurt 2011" @default.
- Q83349493 description "artículu científicu espublizáu en febreru de 2011" @default.
- Q83349493 description "scientific article published on 01 February 2011" @default.
- Q83349493 description "wetenschappelijk artikel" @default.
- Q83349493 description "наукова стаття, опублікована в лютому 2011" @default.
- Q83349493 name "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 name "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 name "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 type Item @default.
- Q83349493 label "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 label "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 label "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 prefLabel "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 prefLabel "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 prefLabel "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 P1433 Q83349493-FD5AA564-225E-4381-82C3-6318C6BA7671 @default.
- Q83349493 P1476 Q83349493-5C132BB5-3147-4379-B6F7-F3357FEE52D5 @default.
- Q83349493 P2093 Q83349493-AFEC94A2-D566-46A1-826C-C9A057CEC03A @default.
- Q83349493 P2093 Q83349493-B342B801-D61D-48A6-B35F-357A5AAE65B3 @default.
- Q83349493 P304 Q83349493-61279E12-E4F4-4452-A954-8BB811D61557 @default.
- Q83349493 P31 Q83349493-55E6F3CB-049D-4B67-BC56-83C25015F596 @default.
- Q83349493 P356 Q83349493-EB0A3206-E5F3-4AFD-AC95-0CC67CDD78F5 @default.
- Q83349493 P433 Q83349493-C31439A8-A6EB-4BD7-BBE7-888907B579F0 @default.
- Q83349493 P478 Q83349493-E468DDE9-4C39-4BE7-A6E4-DED4448A2462 @default.
- Q83349493 P577 Q83349493-E3AD80AD-15D0-41EE-B8A9-97C5D8301A2C @default.
- Q83349493 P698 Q83349493-D5D117DD-814A-413F-A087-927EFF96A94D @default.
- Q83349493 P921 Q83349493-14E95A51-5BDB-44A5-BF56-F167FA6B022E @default.
- Q83349493 P921 Q83349493-27BEA8C4-73EB-4381-AB97-9D76E88D51A5 @default.
- Q83349493 P921 Q83349493-C9C5F493-E1FC-4ACE-8239-379ECDFADAEB @default.
- Q83349493 P356 CNCR.25923 @default.
- Q83349493 P698 21287533 @default.
- Q83349493 P1433 Q326041 @default.
- Q83349493 P1476 "Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial" @default.
- Q83349493 P2093 "Christof Sohn" @default.
- Q83349493 P2093 "Michael H R Eichbaum" @default.
- Q83349493 P304 "3529; author reply 3529-30" @default.
- Q83349493 P31 Q13442814 @default.
- Q83349493 P356 "10.1002/CNCR.25923" @default.
- Q83349493 P433 "15" @default.
- Q83349493 P478 "117" @default.
- Q83349493 P577 "2011-02-01T00:00:00Z" @default.
- Q83349493 P698 "21287533" @default.
- Q83349493 P921 Q18555222 @default.
- Q83349493 P921 Q412415 @default.
- Q83349493 P921 Q42824440 @default.